Cargando…
Hydroxychloroquine in COVID-19 Patients: Pros and Cons
The pandemic of COVID-19, caused by SARS-CoV-2, has recently overwhelmed medical centers and paralyzed economies. The unparalleled public distress caused by this pandemic mandated an urgent quest for an effective approach to manage or treat this disease. Due to their well-established anti-infectious...
Autores principales: | Younis, Nour K., Zareef, Rana O., Al Hassan, Sally N., Bitar, Fadi, Eid, Ali H., Arabi, Mariam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751757/ https://www.ncbi.nlm.nih.gov/pubmed/33364965 http://dx.doi.org/10.3389/fphar.2020.597985 |
Ejemplares similares
-
Aspirin in COVID-19: Pros and Cons
por: Zareef, Rana, et al.
Publicado: (2022) -
Corticosteroids in COVID-19: pros and cons
por: Bahsoun, Aymen, et al.
Publicado: (2023) -
COVID-19 in Pediatric Patients: A Focus on CHD Patients
por: Zareef, Rana O., et al.
Publicado: (2020) -
COVID-19: potential therapeutics for pediatric patients
por: Younis, Nour K., et al.
Publicado: (2021) -
Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)